Immunol. 1, 113-138). We now report that the Ca 2؉ -activated K ؉ channel mIKCa1 modulates mouse Paneth cell secretion. mIKCa1 cDNA clones identified in a mouse small intestinal crypt library by hybridization to human IKCa1 cDNA probes were isolated, and DNA sequence analysis showed that they were identical to mIKCa1 cDNAs isolated from erythroid cells and liver. The genomic organization was found to be conserved between mouse and human IKCa1 as shown by comparisons of the respective cDNA and genomic sequences. Reverse transcriptase-PCR experiments using nested primers amplified mIKCa1 from the lower half of bisected crypts and from single Paneth cells, but not from the upper half of bisected crypts, villus epithelium, or undifferentiated crypt epithelial cells, suggesting a lineage-specific role for mIKCa1 in mouse small bowel epithelium. The cloned mIKCa1 channel was calcium-activated and was blocked by ten structurally diverse peptide and nonpeptide inhibitors with potencies spanning 9 orders of magnitude and indistinguishable from that of the human homologue. Consistent with channel blockade, charybdotoxin, clotrimazole, and the highly selective IKCa1 inhibitors, TRAM-34 and TRAM-39, inhibited (ϳ50%) Paneth cell secretion stimulated by bacteria or bacterial lipopolysaccharide, measured both as bactericidal activity and secreted cryptdin protein, but the inactive analog, TRAM-7, did not block secretion. These results demonstrate that mIKCa1 is modulator of Paneth cell ␣-defensin secretion and disclose an involvement in mucosal defense of the intestinal epithelium against ingested bacterial pathogens.
Gene-encoded antimicrobial peptides are evolutionarily conserved molecules that all known species elaborate as components of innate immunity (1) . Generally containing fewer than 40 amino acids, these biochemically diverse peptides have secondary structures that range from linear ␣-helical molecules to ␤-sheet peptides constrained by up to four disulfide connectivities, including the covalently closed circular -defensins (2) . In mammals, the ␣-defensins are cationic, 3-4-kDa peptides with a characteristic tridisulfide array, and they occur in phagocytic leukocyte granules from which they mediate nonoxidative killing of ingested microbial cells following phagolysosomal fusion (3) (4) (5) . Varied epithelia also express ␣-and ␤-defensins, secreting them onto mucosal surfaces by apparent constitutive pathways or as secretory granule components of exocytotic cells (6 -13) . In crypts of the small intestinal epithelium, Paneth cells accumulate high levels of ␣-defensins that are termed cryptdins in mice, and which they secrete in response to bacterial or pharmacologic stimuli.
Paneth cells participate in innate mucosal immunity by discharging ␣-defensins at millimolar concentrations. Bacteria or bacterial antigens stimulate mouse Paneth cells to release apical secretory granules that contain several bactericidal peptides and proteins of which the cryptdins account for ϳ70% of the secreted microbicidal peptide activity (10) . The secretory responses occur within minutes of exposure to soluble bacterial antigens or to carbamyl choline and are dose-dependent, suggesting a receptor-mediated process (10) . In mouse small intestinal crypts stimulated with carbamyl choline, the cytosolic calcium dynamics change only in Paneth cells in a biphasic pattern consistent with mobilization of intracellular Ca 2ϩ stores followed by influx of extracellular Ca 2ϩ (14, 15) . These observations led to the hypothesis that Paneth cell secretion in response to bacterial stimuli may be modulated by a cationselective channel that could regulate the influx of extracellular Ca 2ϩ .
Intermediate conductance Ca 2ϩ -activated K ϩ channels are the product of the IKCa1 genes (also known as IK1, hKCa4, hSK4, KCNN4) and are important in regulating the membrane potential of colonic epithelial cells, and lymphocytes, and in the volume regulation of red blood cells (16 -20) . IK Ca channels have an intermediate single channel conductance of 11 picosiemens in sodium and 40 picosiemens in potassium Ringer, are voltage-independent, and open in response to changes in intracellular Ca 2ϩ . The protein has six transmembrane segments, internal N and C termini, and its C terminus is complexed to calmodulin, the channel calcium sensor (21) . The azole antimycotic, clotrimazole (CLT), 1 blocks this channel with nanomolar affinity, and triarylmethane analogs of CLT are highly selective and potent inhibitors of the human IKCa1 channel (22) . Scorpion toxin charybdotoxin (ChTX) also blocks hIKCa1, and a selective analog, ChTx-Glu 32 , has been generated by structure-guided design (23) . These highly selective reagents provide probes for analyzing the role of IKCa1 in Ca 2ϩ -mediated signaling events. Because hIKCa1 regulates specific immune responses mediated by T lymphocytes (20, 24) , we tested whether a K Ca channel could participate in innate immune responses to bacteria by modulating calcium signaling during Paneth cell secretion. In this report, mouse Paneth cells in small intestinal epithelium are shown to express mIKCa1, and pharmacologic inhibition of IKCa1 with highly selective triarylmethanes (22) diminished cryptdin secretion in response to bacteria and lipopolysaccharide (LPS).
EXPERIMENTAL PROCEDURES

Preparation of a Mouse Small Intestinal Crypt cDNA Library-
Crypts from the small intestines of adult Swiss Webster mice were prepared using EDTA dissociation (10, (25) (26) (27) . Fractions consisting of Ͼ90% crypts were obtained by agitation of small intestinal segments in nominally Ca 2ϩ , Mg 2ϩ -free phosphate-buffered saline with 30 mM EDTA. Total crypt cellular RNA was isolated (28, 29) , from which poly(A)-containing mRNA was purified by oligo(dT)-cellulose chromatography. A custom cDNA library was constructed by Stratagene Cloning Systems, Inc. (La Jolla, CA) using crypt mRNA as template for reverse transcription of single-stranded cDNA with oligo(dT) 18 -20 to prime the reverse transcriptase reaction from the mRNA 3Ј termini. Double-stranded cDNAs with adapted termini were cloned in the EcoRI and XhoI sites of the phagemid vector Uni-ZAP XR (Stratagene Cloning Systems). Cloning was performed without polymerase chain reaction (PCR) amplification of sequences or size exclusion of low molecular weight mRNAs. The library contained ϳ9.8 ϫ 10 6 primary clones and was amplified to a working titer of 3.9 ϫ 10 10 plaque-forming units/ml. Cloning of Mouse Crypt mIKCa1 cDNA-Bacteriophages containing mIKCa1 were identified in the crypt library by screening ϳ5 ϫ 10 6 plaque-forming units in duplicate by hybridization at 42°C in 1 M NaCl, 50% formamide, 10% dextran sulfate, and 1% SDS with 32 P-labeled probes consisting of 360 bp from the 5Ј-NCR of hIKCa1 (GenBank TM accession number AF033021). Filters were washed three times with continuous agitation at 50°C with 0.5 ϫ SSC (1 ϫ SSC ϭ 150 mM NaCl, 15 mM sodium citrate), 1% SDS, and autoradiograms were exposed at Ϫ70°C. Forty-six positive clones were identified, shown to have identical or overlapping restriction patterns, and all clones sequenced within the IKCa1 coding region were identical to mIKCa1. Plaquepurified phage were excised to plasmid forms and subjected to digestion with restriction enzymes and DNA sequence analysis. All clones corresponded to the mouse Ca 2ϩ -activated K ϩ channel, mIKCa1. The complete mouse intestinal mIKCa1 sequence was determined by cloning the remaining 5Ј-flanking by 5Ј-rapid amplification of cDNA ends using oligonucleotide primers mCK1m1, 5Ј-ATGGC CCCTG AGGTC TTGGG GCTCA GCCAG CTT (nucleotides 145-177 on the mIKCa1 antisense strand); mCK1m2, 5Ј-TGCCC AGGGT CCCCC ACCTC TCAGT ACTGC AAAT (nucleotides 109 -142 on the mIKCa1 antisense strand), and mCK1mR, 5Ј-TTCTC CTGCT CCAGC AGGCG CTTTC TCCGT CTCA (nucleotides 210 -243 on the mIKCa1 antisense strand) as primers in the 5Ј-rapid amplification of cDNA ends System Version 2.0 (Invitrogen). The complete mouse intestinal crypt mIKCa1 cDNA sequence was identical to those reported previously from mouse bone marrow (GenBank TM accession numbers AF042487 and NM008433) and embryonic mouse liver (GenBank TM accession number AK010943). RT-PCR Detection of mIKCa1 mRNA-Intact crypts and villi were prepared as described previously (10) . Crypts were bisected by suspending crypt preparations at low density in 0.6% agarose in PBS at 50°C, poured onto the surface of a microscope slide, and allowed to solidify. Individual crypts were bisected under phase microscopy using pulled capillary pipettes that were broken to produce knife edges. For preparation and isolation of single Paneth cells, crypt preparations were incubated in 2 ml of Hanks' balanced salt solution with 150 units/ml collagenase (Sigma) at 37°C for 15 min. Cells were deposited by centrifugation at 1500 rpm for 5 min in a Beckman GS-6R centrifuge, resuspended, and washed two times with ice-cold PBS, and the preparation was centrifuged through a 30-m filter Cell Strainer cap (Falcon model 352235). Paneth cells and agranular crypt epithelial cells were identified under phase microscopy, drawn into capillary tubes and transferred to PCR reaction tubes for amplification.
For RT-PCR experiments, isolated villi, intact crypts, bisected crypts, or isolated single Paneth cells were transferred to individual microcentrifuge tubes, sonicated in 1 l of RNAguard RNase inhibitor, and stored at Ϫ70°C. Detection of mIKCa1 required that RT-PCR be performed with nested primer sets. RNA from intestinal epithelial cells and structures were amplified with GeneAmp EZ rTth RNA PCR kit (PerkinElmer Life Sciences). Samples (500 ng) of total RNA from mouse bone marrow, spleen, liver, kidney, testis, heart, stomach, small intestine (proximal, mid, distal), cecum, colon, and developing small intestine also were analyzed similarly (data not shown). The external amplimers consisted of primers mIKCa1F1, 5Ј-GCCAG GTACG GCTGA AACAC, which corresponds to nucleotides 1224 -1244 on the mIKCa1 sense strand within exon 7 and mIKCa1R1, 5Ј-CGTGG GAGGT CCAAT TCAGT, which corresponds to nucleotides 1624 -1643 on the mIKCa1 antisense strand in exon 8. Reaction mixes were denatured and subjected to 45 cycles as follows: 94°C, 1 min; 50°C, 1.5 min; 72°C, 2 min with a final extension reaction of 9 min at 72°C terminated by rapid cooling to 4°C.
Detection of mIKCa1 required an additional round of amplification using the following set of internal amplimers: mIKCa1F2, 5Ј-ACATG ATCCT GTGCG ACCTG corresponding to nucleotides 1293-1312 on the mIKCa1 sense strand and also in exon 7 paired with mIKCa1R2, 5Ј-TCAAC GTGGA TCCAC GTGGG corresponding to nucleotides 1567-1586 on the mIKCa1 antisense strand in exon 8. Samples consisting of 5 l of 1:100 dilutions of the initial RT-PCR reaction products were used as template for nested amplification. PCR mixes lacking AmpliTaq DNA Polymerase were preheated at 94°C for 2 min, then complete reaction mixes were cycled as before. Samples of the PCR reactions were analyzed by separation in 2% agarose gels to visualize the 293-bp product, and the fragments were purified with QIAEX II gel extraction kit (Qiagen, Valencia, CA) or transferred to nylon membranes to identify mIKCa1 by hybridization with an hIKCa1 probe (29, 30) . Amplification of mIKCa1 was performed a minimum of four times on unstained, freshly prepared crypts. The 293-bp amplification product was cloned into the TOPO II TA cloning vector (Invitrogen), and its identity as the appropriate region of mIKCa1 sequence was confirmed by DNA sequencing (data not shown).
Inhibition of Paneth Cell Secretion by mIKCa1-specific Blockers-To test for a role for mIKCa1 in Paneth cell secretion, the inhibitory effects of K ϩ channel blockers were tested in an ex vivo crypt assay system as described previously (10, 27) . One-thousand crypts were incubated in 1 ml of isotonic PIPES buffer, consisting of 10 mM PIPES with 0.8% sodium gluconate (pH 7.4), with the appropriate inhibitor plus 10 6 colony-forming units (cfu) Salmonella typhimurium, Escherichia coli, or E. coli LPS (Sigma) or in buffer alone at 37°C for 30 min. Samples of elicited secretions were collected and analyzed for bactericidal activity and in Western blots for cryptdins. Samples (10 l) of collected secretions or control supernatants were tested for bactericidal activity against 1,000 cfu of the defensin-sensitive S. typhimurium phoPϪ strain in 40 l of PIPES buffer, and surviving bacteria were quantitated as cfu on nutrient agar after overnight growth at 37°C (10) . In this assay, ϳ1000 crypts were suspended in 1 ml of a nominally calcium-free medium (10 mM PIPES, 0.8% sodium gluconate (pH 7.4)) and exposed to 1 ϫ 10 6 bacterial cfu per crypt or to 100 ng/ml E. coli LPS to elicit Paneth cell secretion (10) . All experiments were repeated a minumum of three times on freshly prepared crypts.
Western Blot Analysis-Proteins extracted from collected secretions were analyzed for cryptdins by Western blotting following separation by acid-urea PAGE. Briefly, the samples were analyzed on a 12.5% acrylamide acid-urea PAGE gel containing 5 M urea as described previously (10) . For Western blot analysis, resolved Paneth cell protein secretions were transferred from gels to nitrocellulose membranes (0.22 m), and blocked membranes were incubated sequentially with rabbit antimouse cryptdin-1 antibody (1:500), peroxidase-conjugated anti-rabbit IgG (1:10,000), and chemiluminescent substrate (SuperSignal, Pierce), and x-ray films were exposed to blots as described previously (10) .
Electrophysiology of mIKCa1-The mIKCa1 coding region was cloned into pcDNA 3.1, and the construct was transiently transfected into COS-7 cells with FuGENE 6 (Roche Molecular Biochemicals) according to the manufacturer's protocol. The pharmacology of mIKCa1 was determined in the whole cell mode of the patch-clamp technique using a holding potential of Ϫ80 ] were applied to the cytoplasmic side of the patch. CLT, econazole, and tetraethylammonium were from Sigma; nifedipine was from RBI (Natick, MA); ChTX, ChTX-Glu 32 , and ShK (Stichodactyla helianthus toxin) were from Bachem Biosciences (King of Prussia, PA). The synthesis and specificities of ChTX-Glu 32 (23) and the triarylmethanes TRAM-3, TRAM-7, TRAM-34, and TRAM-39 have been described previously (22) .
RESULTS
Cloning of mIKCa1 cDNA from Adult Mouse Small Intestinal
Crypts-A cDNA library prepared from isolated adult mouse small intestinal crypts was screened in duplicate with a probe from the 5Ј-NCR of hIKCa1 (GenBank TM accession number AF033021). Forty-six positive clones with identical or overlapping restriction patterns were identified in the mouse crypt library. The complete 1278-bp coding sequence was obtained in several isolates, but the remaining 175 bp of 5Ј-NCR was determined by 5Ј-rapid amplification of cDNA ends. The composite mIKCa1 sequence contains 302 bp of 5Ј-NCR, 1278 bp of coding sequence, and 496 bp of 3Ј-NCR. The sequence is identical to amplified mIKCa1 coding regions from the MEL murine erythroleukemia cell line characterized previously (GenBankTM accession numbers AF042487, AF072884, and NM_008433) and with full-length mIKCa1 cDNA from mouse embryonic liver (GenBankTM accession number AK010943). mIKCa1 cDNA alignments with existing mouse genomic DNA sequences (GenBankTM accession numbers AC073693 and AC073810) showed that the intron-exon organization of the mIKCa1 gene is identical to that in the hIKCa1 homologue (Fig. 1) . Comparison of the hIKCa1 cDNA and genomic sequences (GenBankTM accession numbers AF022797 and AF305731-AF305735) with mIKCa1 sequences revealed Ͼ90% nucleotide sequence identity from nucleotide 97 of the human transcript through the coding region and 3Ј-NCR. The hIKCa1 coding region is 6 nucleotides longer than mIKCa1, coding for two additional residues in the S3-S4 loop. The deduced mIKCa1 protein differs from hIKCa1 at 53 additional positions, most differences being in the S2 and S3 segments, and in the C terminus. These cloning results show that mIKCa1 is expressed by mouse small intestinal crypt epithelium.
mIKCa1 mRNA Is Expressed Selectively in Paneth Cells in the Mouse Small Intestine-The intestinal epithelial cell lineages that express the mIKCa1 gene in mouse small intestinal epithelium were determined using a nested RT-PCR assay. Consistent with previous reports (18, 20) , RT-PCR analysis of whole organ RNA showed that mIKCa1 mRNA was present in adult mouse bone marrow, spleen, liver, kidney, testis, heart, stomach, small intestine, cecum, and colon (data not shown). Also, mIKCa1 mRNA was amplified equivalently from whole organ RNA throughout the gastrointestinal tract, and its detection in neonatal mouse small bowel RNA (not shown) showed that mIKCa1 gene expression precedes crypt ontogeny and the differentiation of epithelial cell lineages. Because amplification of whole organ RNA provides no information as to sites of gene expression, we attempted to determine the cell types expressing mIKCa1 mRNA in small bowel by in situ hybridization. However, mIKCa1 mRNA levels were insufficient to detect hybridization, and therefore small intestinal mIKCa1 expression was investigated by the RT-PCR analysis of isolated epithelial structures and cells.
In mice, Paneth cells were the primary small intestinal epithelial cell lineage found to express mIKCa1. To identify the small intestinal cell types expressing mIKCa1, nested RT-PCR assays were performed on isolated intact villus epithelium ( Fig.  2A, "arrow a" ), intact crypts ( Fig. 2A, "arrow b" ), bisected crypts ( Fig. 2A, "arrows c and d") , single Paneth cells ( Fig. 2A, "arrows  g and h" ), or single undifferentiated crypt cells ( Fig. 2A, " arrows i and j"). Individual structures or cells were transferred to separate microfuge tubes, mIKCa1 cDNA was amplified using sequence-specific nested amplimers, and the products were analyzed by gel electrophoresis (see "Experimental Procedures"). mIKCa1 mRNA was detected in intact crypts (Fig. 2B,  lane b) but not in villus epithelium (Fig. 2B, lane a) , and analyses of bisected crypts showed that mIKCa1 mRNA was present only in the lower portion of the crypt (Fig. 2B, lane d) but not in the upper half (Fig. 2B, lane c) . Since the lower half of the crypt contains Paneth cells as well as undifferentiated crypt epithelial cells that are agranular, RT-PCR assays were conducted on both these cell populations isolated from single cell suspensions of isolated crypts (see "Experimental Procedures"). Although Fig. 2 shows Paneth cells in crypts stained selectively with Amido Black (see "Experimental Procedures"), all RT-PCR experiments reported here were performed on unstained crypts and are representative of four separate determinations. Single cell RT-PCR detected mIKCa1 mRNA only in Paneth cells (Fig. 2B, lanes g and h, respectively, containing one or five individual Paneth cells), but not in agranular crypt epithelial cells (Fig. 2B , lanes i and j, one or five cells, respectively). Glyceraldehyde-3-phosphate dehydrogenase mRNA was amplified using RNA from all sources in Fig. 2 that were negative for mIKCa1 products (data not shown). Hybridization of a mIKCa1 cDNA probe to a Southern blot of the gel shown in the upper panel of Fig. 2B was consistent with identification of the amplification products as mIKCa1 sequences (Fig. 2B,  lower panel) . The authenticity of the amplified products was verified by DNA sequence analysis (data not shown).
mIKCa1 and hIKCa1 Are Pharmacologically Indistinguishable-Because mouse and human IKCa1 differ at 55 amino acid residue positions (13% difference), we compared the properties of the mouse channel heterologously expressed in COS-7 cells with that of human IKCa1. In the representative insideout patch shown in Fig. 3A , mIKCa1 currents were induced by 1 M free Ca 2ϩ , but not by 50 nM Ca 2ϩ , confirming the Ca 2ϩ dependence of this channel. In experiments done in the whole cell mode, the reversal potential of the mIKCa1 current shifted from Ϫ80 mV in sodium Ringer solution to 0 mV in potassium Ringer, consistent with the channel being potassium-selective (Fig. 3B) . We also conducted a detailed pharmacological analysis of mIKCa1 using a panel of ten inhibitors that are known to block hIKCa1 in a potency range spanning 9 log units (20, 21) . Representative traces for four compounds (TRAM-34, ChTX-Glu 32 , CLT, and TRAM-7) are shown in Fig. 3 , C-F, and dose-response curves for all ten compounds are shown in detail in Fig. 3G . The K d -values (mean ϩ S.D.) obtained for the mouse channel are identical to those reported for the human homologue, hIKCa1 (20, 21) . Earlier published data demonstrated that the single channel conductances of mIKCa1 and hIKCa1 are identical (17, 18) . Taken together, these findings show that the biophysical and pharmacological properties of the mIKCa1 channel are indistinguishable from those of hIKCa1, allowing the previously characterized and selective inhibitors of hIKCa1, TRAM-34, TRAM-39, and ChTX-Glu 32 to be applied to functional studies of mIKCa1 in Paneth cells. channel blockers were tested as inhibitors of Paneth cell ␣-defensin secretion following exposure to S. typhimurium or E. coli or to 100 ng/ml LPS for 30 min (10). Because cryptdins localize exclusively to Paneth cell secretory granules in the small intestine and account for 70% of the bactericidal activity in Paneth cell secretions (10), bactericidal peptide activity assays provide a sensitive and accurate index of Paneth cell secretion. Accordingly, the effects of IKCa1 blockers on secretory activity were evaluated by measuring antimicrobial peptide activity in elicited secretions, and cryptdin secretion was confirmed biochemically by Western blot analyses.
In the presence of 1 M ChTX-Glu 32 or CLT, the quantity of bactericidal activity secreted by Paneth cells in crypts exposed to S. typhimurium was inhibited by ϳ50% compared with crypts not exposed to blockers (Fig. 4A ). Further studies with CLT showed that the inhibition was dose-dependent (Fig. 4B) , and similar results were obtained with crypts exposed to 1000 cfu/crypt E. coli (data not shown). Although these findings were consistent with the involvement of mIKCa1 in Paneth cell secretory responses to bacteria, we perceived the need to test additional inhibitory agents with greater specificities. For example, ChTX, an agent used in preliminary experiments (Fig.  4C and data not shown) also blocks the BK Ca , Kv1.2, and Kv1.3 channels (31), and CLT inhibits cytochrome P450-dependent enzymes (32) (33) (34) in the concentration range that blocks mIKCa1 (Fig. 3) . Therefore, to test for mIKCa1 involvement in Paneth cell secretion of bactericidal peptide activity more specifically, the inhibitory effects of more selective mIKCa1 blockers were evaluated. As shown in Fig. 4, A and C (Fig. 3) , inhibited bacterial and LPS-stimulated secretion of bactericidal peptide activity to the same extent as ChTX (Fig. 4C) . The highly selective IKCa1 blockers TRAM-34 and TRAM-39 also inhibited LPS-triggered Paneth cell release of bactericidal peptide activity at 200 nM, nearly equivalent to the level of inhibition obtained using 1 M CLT. On the other hand, the inactive analog TRAM-7 had no measurable inhibitory effect on secretion (Fig. 4C) . None of the inhibitors was inherently bactericidal, and none stimulated Paneth cells to release granules (data not shown). These findings implicate the mIKCa1 channel as a specific modulator of Paneth cell ␣-defensin release in response to bacteria or LPS.
To evaluate the effects of mIKCa1 blockers on cryptdin secretion, Paneth cell secretions collected from crypts exposed to bacteria (Fig. 4, A and B) or LPS (Fig. 4C) were dialyzed, separated by acid-urea PAGE, and probed in Western blots with anti-cryptdin-1 antibody (Fig. 5) . As reported previously (10), S. typhimurium evoked secretion of activated cryptdins (Fig. 5, A and B, lanes 1) , and no measurable cryptdin was released when crypts were incubated for 30 min in isotonic buffer without stimuli (Fig. 5A, lane 4; Fig. 5B, lane 5) . Consistent with the inhibitory effects of ChTX-Glu 32 and CLT on release of bactericidal peptide activity (Fig. 4, A and B) , 1 M ChTX-Glu 32 or 1 M CLT reduced cryptdin-specific immunoreactivity in Paneth cell secretions elicited by bacteria (Fig. 5A) , and this effect was dose-dependent (Fig. 5B) . CLT (1 M) and the specific IKCa1 inhibitors TRAM-34 and TRAM-39 (200 nM) also diminished LPS-induced cryptdin release from Paneth cells (Fig. 5C ). These findings and those in Fig. 4 provide evidence that mIKCa1 has a role in Paneth cell secretion in response to infectious challenge, disclosing potential implications for innate immunity in small intestinal crypts exposed to bacteria.
DISCUSSION
From evidence of their secretion of cryptdins in response to bacteria and bacterial antigens, Paneth cells are inferred to participate in innate immunity in the crypt microenvironment and perhaps above the crypt-villus junction as well (10, 27) . The highly restricted expression of mIKCa1 in Paneth cells of the small bowel, and the inhibition of bacterial stimulated Paneth cell secretion by highly selective mIKCa1 blockers, identify mIKCa1 as a functional marker for Paneth cells. Other intestinal cells may express mIKCa1 at levels below the detection limits of our assays.
Carbamyl choline-induced Paneth cell secretion is associated with a biphasic increase in cytosolic [Ca 2ϩ ], where the first rise in Ca 2ϩ derives from intracellular stores and the second is dependent on uptake of exogenous Ca 2ϩ (15) . The involvement of the Ca 2ϩ -activated mIKCa1 channel in Paneth cell secretory responses to bacteria and LPS suggests a role for cytosolic [Ca 2ϩ ] in this process as well. By analogy to events in human lymphocytes during the specific immune response, mIKCa1 channels in the Paneth cell membrane would open as cytosolic [Ca 2ϩ ] approaches 300 nM, providing the counterbalancing cation efflux necessary to sustain Ca 2ϩ entry from the external (20, 24, 35) . Blockade of mIKCa1 would depolarize the membrane and attenuate the calcium signaling response required to generate a complete Paneth cell secretory response. The mIKCa1 channel may also influence secretion of antimicrobial peptides from other mucosa in the airway, gingival crevice, oropharynx, or urogenital epithelium. The involvement of mIKCa1 in Paneth cell secretion as shown here does not exclude potential roles for other subtypes of calcium-activated K ϩ channels in antimicrobial peptide secretion by any of these cells.
CLT is being evaluated in human clinical trials for the treatment of secretory diarrheas due to its ability to block IKCa1 in the colonic epithelium (36, 37) . Our finding that highly selective blockers of the IKCa1 channel diminish secretion of Paneth cell antimicrobial peptides in response to bacterial exposure suggests that IKCa1 blockade may have deleterious effects on innate immune mechanisms in the small intestine. To our knowledge, Paneth cell dysfunction has not been identified with human disease. However, in mice genetically defective for the procryptdin-activating metalloproteinase matrilynM TRAM-34, 100 nM ChTX-Glu 32 , 100 nM CLT, and 10 M TRAM-7 on representative whole-cell IK currents. G, pharmacology of mIKCa1. K d values were determined by testing every compound three times at four concentrations and fitting the Hill equation (n H ) to the reduction of slope conductance at Ϫ80 mV. Mean ϩ S.D. are shown. f,
FIG. 4. Effects of mIKCa1 inhibition on Paneth cell secretion of bactericidal peptide activity.
A, secretions were collected from crypts (ϳ1000) resuspended in isotonic sodium gluconate buffer containing 1 M CLT or 1 M ChTX-Glu 32 coincubated with S. typhimurium at 37°C for 30 min. Stimulated secretions or control supernatants were collected, and the bactericidal activity of 10-l samples were tested against ϳ500 cfu of defensin-sensitive S. typhimurium (10) . Surviving bacteria were quantitated as colony-forming units following overnight growth. Data points represent individual triplicate determinations in two separate experiments. For each series of data points, plus characters denote presence of S. typhimurium with crypts as bacterial secretory stimuli, and minus signs denote crypts incubated in the absence of bacteria as negative controls for secretion. Similarly, CLT or ChTX-Glu 32 blocking agents were present as noted, and minus signs denote crypts incubated in the absence of either blocker. B, secretions were collected from crypts stimulated with S. typhimurium in the presence of increasing concentrations of CLT, and the bactericidal activity of 10-l samples of secretions was assayed as described in A and expressed as mean percent inhibition of bacterial cell killing Ϯ S.D. (n ϭ 3), relative to secretions stimulated by S. typhimurium in the absence of blocking agent. C, secretions were collected from crypts stimulated with 100 ng/ml LPS in the presence or absence of 200 nM TRAM-34, TRAM-39, or TRAM-7 or 1 M CLT, ChTX, or ChTX-Glu 32 as in B. The bactericidal activity of 10-l samples was measured and expressed as described in B, relative to secretions released by stimulation with LPS in the absence of IKCa1 inhibitors.
sin, the lack of activated intestinal ␣-defensins correlates with a diminished ability of the mice to clear orally administered enteric infections, and matrilysin-null mice are 10-fold more susceptible to systemic disease caused by S. typhimurium infection (27) . Defects in mIKCa1 expression or function could adversely affect enteric host defense by attenuating secretory responses to infection and perhaps increasing host susceptibility to bacterial colonization. Fig. 4A) , increasing dosages of CLT (Fig. 4B) , or with 100 ng/ml LPS in the presence of 200 M TRAM-34, TRAM-39, or 1 M CLT (Fig.  4C ). Cryptdins were detected by Western blot analysis following acidurea PAGE (see "Experimental Procedures" (10) , and arrows indicate immunoreactive cryptdins in all panels. Lanes: plus characters denote presence of bacterial or LPS secretory stimuli as noted, and minus characters denote absence of a bacterial or LPS secretory stimulus. Similarly, plus and minus characters denote the respective presence or absence of blockers as noted. Crp1 denotes lanes containing 1 g of synthetic cryptdin-1.
mIKCa1 in Paneth Cell Secretion
